A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Clinical trial NCT06548360 · RECRUITING
Trial details
- NCT number
- NCT06548360
- Sponsor
- Incyte Corporation
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-24
- Primary completion
- 2026-08-10
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.